Analisi sito web pharmaphorum.com
pharmaphorum | News & views on pharma and biotech’s evolving future
Generato il Marzo 06 2026 13:56 PM
Statistiche non aggiornate? AGGIORNA !
Il punteggio e 56/100
SEO Content
Title
pharmaphorum | News & views on pharma and biotech’s evolving future
Lunghezza : 67
Perfetto, il tuo title contiene tra 10 e 70 caratteri.
Description
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Lunghezza : 158
Grande, la tua meta description contiene tra 70 e 160 caratteri.
Keywords
Molto male. Non abbiamo trovato meta keywords nella tua pagina. Usa questo generatore gratuito online di meta tags per creare keywords.
Og Meta Properties
Buono, questa pagina sfrutta i vantaggi Og Properties.
| Proprieta | Contenuto |
|---|---|
| site_name | pharmaphorum |
| url | https://pharmaphorum.com/homepage |
| title | pharmaphorum| News & views on pharma and biotech’s evolving future |
| description | Pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future. |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 0 | 7 | 37 | 0 | 12 | 0 |
- [H2] Featured Content
- [H2] Latest News
- [H2] Views & Analysis
- [H2] Deep Dive
- [H2] White Papers & Webinar
- [H2] Podcasts & Video
- [H2] Partner Content
- [H3] China's clears Pfizer GLP-1 ecnoglutide for weight loss
- [H3] J&J's Tecvayli claims third national priority FDA approval
- [H3] The GLP-1 Reckoning
- [H3] Alnylam bets on Tenaya RNAi tech, and other licensing news
- [H3] What US healthcare companies and medical researchers need to...
- [H3] What US healthcare companies and medical researchers need to...
- [H3] The GLP-1 Reckoning
- [H3] Using AI-driven synthetic personas to take your insights fur...
- [H3] AI in clinical development & ‘white space’, with Andrew Mack...
- [H3] New hope for ovarian cancer, with Alexander Schneider
- [H3] Expert Directed Applied Intelligence: Redefining AI in Life ...
- [H3] Editor's Picks
- [H3] China's clears Pfizer GLP-1 ecnoglutide for weight loss
- [H3] J&J's Tecvayli claims third national priority FDA approval
- [H3] Alnylam bets on Tenaya RNAi tech, and other licensing news
- [H3] Lilly unveils employer scheme for weight-loss drug Zepbound
- [H3] What US healthcare companies and medical researchers need to...
- [H3] JPM 2026: What it revealed about biotech’s new reality
- [H3] Pharma’s search loophole is a preview of what comes next
- [H3] Legacy data into living scientific memory
- [H3] The GLP-1 Reckoning
- [H3] GLP-1s: Five years that changed metabolic medicine
- [H3] Redesigning obesity trials for a chronic disease era
- [H3] The trust gap: GLP-1s and the new information economy of obe...
- [H3] Using AI-driven synthetic personas to take your insights fur...
- [H3] Expert Directed Applied Intelligence: Redefining AI in Life ...
- [H3] The strategic imperative of Integrated Evidence Generation P...
- [H3] Data managers and CRAs warn of rising data quality risks due...
- [H3] AI in clinical development & ‘white space’, with Andrew Mack...
- [H3] Collaboration & personalisation in rare disease R&D, with AO...
- [H3] Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al...
- [H3] On JPM2026 and healthcare investment today, with Jonah Comst...
- [H3] 7th Dermatology Drug Development Summit Europe
- [H3] The PM Society Launches Pharmony to Support More Effective P...
- [H3] EVERSANA Names Monica Avram Executive Vice President and Chi...
- [H3] Emerging Trends in Personalised Medicine at PHARMAP 2026
- [H3] Book your tickets and join the PM Society for the 40th PM Aw...
- [H5] header links
- [H5] Pharmaphorum menu first category
- [H5] SECTION
- [H5] Channels
- [H5] Channels
- [H5] SUB NAVIGATION
- [H5] US lawmakers take FDA to task over rare diseases record
- [H5] Gilead buys cell therapy partner Arcellx for up to $7.8bn
- [H5] What next for pharma as SCOTUS strikes down Trump tariffs?
- [H5] Novo Nordisk to cut GLP-1 prices in tough US market
- [H5] UK spurs prescribing of obesity jab Mounjaro with GP bonus
- [H5] Pharmaphorum Menu
Images
Abbiamo trovato 42 immagini in questa pagina web.
Buono, molte o tutte le tue immagini hanno attributo alt
Text/HTML Ratio
Ratio : 18%
Buono, il rapporto testo/codice HTML di questa pagina e maggiore di 15, e minore di 25 percento.
Flash
Perfetto, non e stato rilevato contenuto Flash in questa pagina.
Iframe
Molto male, hai usato Iframes nelle tue pagine web, questo significa che in contenuto inserito negli Iframe non puo essere indicizzato.
SEO Links
URL Rewrite
Buono. I tuoi links appaiono friendly!
Underscores in the URLs
Abbiamo rilevato underscores nei tuoi URLs. Dovresti utilizzare trattini per ottimizzare le pagine per il tuo SEO.
In-page links
Abbiamo trovato un totale di 136 links inclusi 1 link(s) a files
| Anchor | Type | Juice |
|---|---|---|
| Skip to main content | Interno | Passing Juice |
| BlueSky | Externo | Passing Juice |
| Externo | Passing Juice | |
| youtube | Externo | Passing Juice |
| Get Newsletters | Interno | Passing Juice |
| Media Kit | Interno | Passing Juice |
| News | Interno | Passing Juice |
| Views & Analysis | Interno | Passing Juice |
| Deep Dive | Interno | Passing Juice |
| Equity and Sustainability | Interno | Passing Juice |
| Research & Development | Interno | Passing Juice |
| Market Access | Interno | Passing Juice |
| Oncology | Interno | Passing Juice |
| Artificial Intelligence | Interno | Passing Juice |
| Patients & Partnerships | Interno | Passing Juice |
| GLP-1 | Interno | Passing Juice |
| Previous Editions | Interno | Passing Juice |
| Webinars | Interno | Passing Juice |
| Podcasts | Interno | Passing Juice |
| Videos | Interno | Passing Juice |
| Spotlight on | Interno | Passing Juice |
| ASCO 2025 | Interno | Passing Juice |
| BIO 2025 | Interno | Passing Juice |
| C-Suite Innovators | Interno | Passing Juice |
| ESMO 2025 | Interno | Passing Juice |
| Frontiers Health 2025 | Interno | Passing Juice |
| JP Morgan | Interno | Passing Juice |
| Global Policy Insights | Interno | Passing Juice |
| Events | Interno | Passing Juice |
| close | Externo | Passing Juice |
| Market Access | Interno | Passing Juice |
| Oncology | Interno | Passing Juice |
| Patients & Partnerships | Interno | Passing Juice |
| Commercialisation | Interno | Passing Juice |
| White Papers | Interno | Passing Juice |
| Sales & Marketing | Interno | Passing Juice |
| R&D | Interno | Passing Juice |
| Digital | Interno | Passing Juice |
| Market Access | Interno | Passing Juice |
| Oncology | Interno | Passing Juice |
| Patients | Interno | Passing Juice |
| Live Coverage | Interno | Passing Juice |
| Partner Content | Interno | Passing Juice |
| About us | Interno | Passing Juice |
| Contribute | Interno | Passing Juice |
| Contact us | Interno | Passing Juice |
| Sign in | Interno | Passing Juice |
| China's clears Pfizer GLP-1 ecnoglutide for weight loss | Interno | Passing Juice |
| J&J's Tecvayli claims third national priority FDA approval | Interno | Passing Juice |
| The GLP-1 Reckoning | Interno | Passing Juice |
| Alnylam bets on Tenaya RNAi tech, and other licensing news | Interno | Passing Juice |
| What US healthcare companies and medical researchers need to... | Interno | Passing Juice |
| Using AI-driven synthetic personas to take your insights fur... | Interno | Passing Juice |
| AI in clinical development & ‘white space’, with Andrew Mack... | Interno | Passing Juice |
| New hope for ovarian cancer, with Alexander Schneider | Interno | Passing Juice |
| Expert Directed Applied Intelligence: Redefining AI in Life ... | Interno | Passing Juice |
| US lawmakers take FDA to task over rare diseases record | Interno | Passing Juice |
| Gilead buys cell therapy partner Arcellx for up to $7.8bn | Interno | Passing Juice |
| What next for pharma as SCOTUS strikes down Trump tariffs? | Interno | Passing Juice |
| Novo Nordisk to cut GLP-1 prices in tough US market | Interno | Passing Juice |
| UK spurs prescribing of obesity jab Mounjaro with GP bonus | Interno | Passing Juice |
| Subscribe | Interno | Passing Juice |
| Lilly unveils employer scheme for weight-loss drug Zepbound | Interno | Passing Juice |
| JPM 2026: What it revealed about biotech’s new reality | Interno | Passing Juice |
| Pharma’s search loophole is a preview of what comes next | Interno | Passing Juice |
| Legacy data into living scientific memory | Interno | Passing Juice |
| GLP-1s: Five years that changed metabolic medicine | Interno | Passing Juice |
| Redesigning obesity trials for a chronic disease era | Interno | Passing Juice |
| The trust gap: GLP-1s and the new information economy of obe... | Interno | Passing Juice |
| The strategic imperative of Integrated Evidence Generation P... | Interno | Passing Juice |
| Data managers and CRAs warn of rising data quality risks due... | Interno | Passing Juice |
| Collaboration & personalisation in rare disease R&D, with AO... | Interno | Passing Juice |
| Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al... | Interno | Passing Juice |
| On JPM2026 and healthcare investment today, with Jonah Comst... | Interno | Passing Juice |
| 7th Dermatology Drug Development Summit Europe | Interno | Passing Juice |
| The PM Society Launches Pharmony to Support More Effective P... | Interno | Passing Juice |
| EVERSANA Names Monica Avram Executive Vice President and Chi... | Interno | Passing Juice |
| Emerging Trends in Personalised Medicine at PHARMAP 2026 | Interno | Passing Juice |
| Book your tickets and join the PM Society for the 40th PM Aw... | Interno | Passing Juice |
| News | Interno | Passing Juice |
| Views & Analysis | Interno | Passing Juice |
| Deep Dive | Interno | Passing Juice |
| Webinars | Interno | Passing Juice |
| Podcasts | Interno | Passing Juice |
| Video | Interno | Passing Juice |
| White Papers | Interno | Passing Juice |
| Event | Interno | Passing Juice |
| News | Interno | Passing Juice |
| Views & Analysis | Interno | Passing Juice |
| Deep Dive | Interno | Passing Juice |
| Webinars | Interno | Passing Juice |
| Podcasts | Interno | Passing Juice |
| Video | Interno | Passing Juice |
| White Papers | Interno | Passing Juice |
| Event | Interno | Passing Juice |
| News | Interno | Passing Juice |
| Views & Analysis | Interno | Passing Juice |
| Deep Dive | Interno | Passing Juice |
| Webinars | Interno | Passing Juice |
| Podcasts | Interno | Passing Juice |
| Video | Interno | Passing Juice |
| White Papers | Interno | Passing Juice |
| Event | Interno | Passing Juice |
| News | Interno | Passing Juice |
| Views & Analysis | Interno | Passing Juice |
| Deep Dive | Interno | Passing Juice |
| Webinars | Interno | Passing Juice |
| Podcasts | Interno | Passing Juice |
| Video | Interno | Passing Juice |
| White Papers | Interno | Passing Juice |
| Event | Interno | Passing Juice |
| News | Interno | Passing Juice |
| Views & Analysis | Interno | Passing Juice |
| Deep Dive | Interno | Passing Juice |
| Webinars | Interno | Passing Juice |
| Podcasts | Interno | Passing Juice |
| Video | Interno | Passing Juice |
| White Papers | Interno | Passing Juice |
| Event | Interno | Passing Juice |
| News | Interno | Passing Juice |
| Views & Analysis | Interno | Passing Juice |
| Deep Dive | Interno | Passing Juice |
| Webinars | Interno | Passing Juice |
| Podcasts | Interno | Passing Juice |
| Video | Interno | Passing Juice |
| White Papers | Interno | Passing Juice |
| Event | Interno | Passing Juice |
| Axtria Ignite 2025 | Interno | Passing Juice |
| Frontiers Health 2024 | Interno | Passing Juice |
| Life Science Industry Report | Interno | Passing Juice |
| World Without Disease Summit | Interno | Passing Juice |
| Pharmaphorum | Interno | Passing Juice |
| Cookie Policy | Interno | Passing Juice |
| Privacy Policy | Interno | Passing Juice |
| Terms & Conditions | Interno | Passing Juice |
| Work for us | Interno | Passing Juice |
SEO Keywords
Keywords Cloud
dive white digital sponsored glp-1 content healthcare pharmaphorum news event
Consistenza Keywords
| Keyword | Contenuto | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| news | 17 |  |
 |
|
|
| white | 11 | |
|
|
|
| event | 10 | |
|
|
|
| healthcare | 9 | |
|
|
|
| content | 9 | |
|
|
|
Usabilita
Url
Dominio : pharmaphorum.com
Lunghezza : 16
Favicon
Grande, il tuo sito usa una favicon.
Stampabilita
Non abbiamo riscontrato codice CSS Print-Friendly.
Lingua
Buono. La tua lingua dichiarata en.
Dublin Core
Questa pagina non sfrutta i vantaggi di Dublin Core.
Documento
Doctype
HTML 5
Encoding
Perfetto. Hai dichiarato che il tuo charset e UTF-8.
Validita W3C
Errori : 0
Avvisi : 0
Email Privacy
Grande. Nessun indirizzo mail e stato trovato in plain text!
Deprecated HTML
Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.
Suggerimenti per velocizzare
|
Eccellente, il tuo sito web non utilizza nested tables. |
|
Molto male, il tuo sito web utilizza stili CSS inline. |
|
Grande, il tuo sito web ha pochi file CSS. |
|
Molto male, il tuo sito web ha troppi file JS (piu di 6). |
|
Perfetto, il vostro sito si avvale di gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Ottimizzazione
XML Sitemap
Grande, il vostro sito ha una sitemap XML.
| https://pharmaphorum.com/sitemap.xml |
Robots.txt
https://pharmaphorum.com/robots.txt
Grande, il vostro sito ha un file robots.txt.
Analytics
Grande, il vostro sito ha uno strumento di analisi dei dati.
Google Analytics |
PageSpeed Insights
Dispositivo
Categorie
Free SEO Testing Tool
Free SEO Testing Tool e uno strumento di ottimizzazione per i motori di ricerca (seo tool) che serve per analizzare le tue pagine web